Morgan Stanley’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $51.8M | Sell |
|
|||||
|
2025
Q1 | $49.1M | Sell |
|
|||||
|
2024
Q4 | $82M | Buy |
|
|||||
|
2024
Q3 | $36.2M | Sell |
|
|||||
|
2024
Q2 | $36.1M | Sell |
|
|||||
|
2024
Q1 | $56.2M | Sell |
|
|||||
|
2023
Q4 | $105M | Sell |
|
|||||
|
2023
Q3 | $89.3M | Sell |
|
|||||
|
2023
Q2 | $115M | Sell |
|
|||||
|
2023
Q1 | $125M | Buy |
|
|||||
|
2022
Q4 | $102M | Sell |
|
|||||
|
2022
Q3 | $164M | Buy |
|
|||||
|
2022
Q2 | $108M | Sell |
|
|||||
|
2022
Q1 | $192M | Buy |
|
|||||
|
2021
Q4 | $222M | Sell |
|
|||||
|
2021
Q3 | $279M | Buy |
|
|||||
|
2021
Q2 | $296M | Sell |
|
|||||
|
2021
Q1 | $298M | Buy |
|
|||||
|
2020
Q4 | $241M | Buy |
|
|||||
|
2020
Q3 | $123M | Buy |
|
|||||
|
2020
Q2 | $78.7M | Buy |
|
|||||
|
2020
Q1 | $36.3M | Buy |
|
|||||
|
2019
Q4 | $27.4M | Buy |
|
|||||
|
2019
Q3 | $19.5M | Buy |
|
|||||
|
2019
Q2 | $20.9M | Buy |
|
|||||
|
2019
Q1 | $17.8M | Buy |
|
|||||
|
2018
Q4 | $11.3M | Sell |
|
|||||
|
2018
Q3 | $17.5M | Buy |
|
|||||
|
2018
Q2 | $11.1M | Buy |
|
|||||
|
2018
Q1 | $6.49M | Buy |
|
|||||
|
2017
Q4 | $2.18M | Buy |
|
|||||
|
2017
Q3 | $879K | Buy |
|
|||||
|
2017
Q2 | $1K | Buy |
|